Biotechnology and Pharmaceuticals Pharmaceuticals Biopharmaceuticals Outsource ServicesCambrex Corporation Investors | About Cambrex | Contact Us | Careers | Login Search Site Advanced Search Site Map Lonza Sale Cambrex has completed the sale of the Research Products and Microbial Biopharmaceutical business to Lonza. Please use the links below for redirection to their site. ? Research Products Custom Media Flexible Packaging Endotoxin Detection Cell Therapy Testing Services // Provide alternate content for browsers that do not support scripting // or for those that have scripting disabled. Thi
Biotechnology and Pharmaceuticals Pharmaceuticals Biopharmaceuticals Outsource ServicesCambrex Corporation Investors | About Cambrex | Contact Us | Careers | Login Search Site Advanced Search Site Map Lonza Sale Cambrex has completed the sale of the Research Products and Microbial Biopharmaceutical business to Lonza. Please use the links below for redirection to their site. ? Research Products Custom Media Flexible Packaging Endotoxin Detection Cell Therapy Testing Services // Provide alternate content for browsers that do not support scripting // or for those that have scripting disabled. Thi
Polymers Processing Methods Molding Injection MoldingPlastic Injection Molding - Medical & Pharmaceutical Device Contract Manufacturing - CJ Industries Home C & J Industries is a full-service, custom manufacturer of high precision plastic injection molds , custom molded plastic components and complete contract assemblies. As a custom plastic injection molder , C & J has expertise in processing both engineering and commodity grade plastics in 50 presses ranging from 20 to 720 tons of clamping pressure. Since we began in business 45 years ago, C & J Industries has expanded our capabilities signi
Biotechnology and Pharmaceuticals PharmaceuticalsBoehringer Ingelheim Corporate Website: Human Pharmaceuticals and Health Care, Animal Health Business Please follow this link , if your browser does not support automatic page refreshing.
Biotechnology and Pharmaceuticals PharmaceuticalsBayer - Homepage Home Bayer Group Overview Profile and Organization Mission Statement Bayer Worldwide Corporate Compliance Corporate Governance History Board of Management Supervisory Board Publications Calendar webReport Research & Innovation Overview Research at Bayer Inventive Talent webReport Products Overview Subgroups Products from A to Z webReport Sustainability & Commitment Overview Motivation Social Initiatives Sustainability webReport leer Special Interest Investor Relations Press Jobs and Career Sports BayKomm Subgroups Bayer HealthCa
Biotechnology and Pharmaceuticals PharmaceuticalsBayer - Homepage Home Bayer Group Overview Profile and Organization Mission Statement Bayer Worldwide Corporate Compliance Corporate Governance History Board of Management Supervisory Board Publications Calendar webReport Research & Innovation Overview Research at Bayer Inventive Talent webReport Products Overview Subgroups Products from A to Z webReport Sustainability & Commitment Overview Motivation Social Initiatives Sustainability webReport leer Special Interest Investor Relations Press Jobs and Career Sports BayKomm Subgroups Bayer HealthCa
Industrial Goods and Services Process Equipment Separators Size ChangingBauermeister USA Inc, Experts in size reduction. SKIP INTRO Bauermeister, a world leader in size reduction and powder processing equipment, offers grinders, pulverizers, roll crushers, flakers and separation equipment for the powder and bulk market with our Universal Mills, Gap Mills, Roller Mills, Air Classifiers we handle a wide range of milling applications. You'll find our equipment processing sugar, food, confectionary, fertilizers, chemicals, cosmetics, minerals, spices, pigments, oil seeds, pharmaceuticals, lactose,
Biotechnology and Pharmaceuticals PharmaceuticalsAxcan Pharma Inc. - Home Page Investors Stock Quotes Quarterly Results Axcan at a glance Axcan is Honored 2006 Annual Report Axcan in the News Axcan Pharma Completes Redemption and Conversion of all $125 Million 4.25% Convertible Subordinated Notes Due 2008 Axcan Pharma Submits CMC Portion of its New Drug Application for ULTRASE and is Granted Fast Track Status Axcan Pharma Initiates MAX-002 Phase III Clinical Trial to Evaluate the Efficacy and Safety of a High-Concentration 1 Gram Mesalamine Suppository Interview with President & CEO Axcan at N